- Schram Mandy Elvira, Roekevisch Evelien, Leeflang Mariska Maria Geertruida, Bos Jan Dositheus, Schmitt Jochen, Spuls Phyllis Ira A randomized trial of methotrexate versus azathioprine for severe atopic eczema Journal of allergy and clinical immunology 2011;128 (2):353-359 [PubMed]
- Roekevisch Evelien, Spuls Phyllis Ira, Kuester Denise, Limpens Jacqueline, Schmitt Jochen Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review Journal of allergy and clinical immunology 2014;133 (2):429-438 [PubMed]
- Schmitt Jochen, Apfelbacher Christian, Spuls Phyllis I., Thomas Kim S., Simpson Eric L., Furue Masutaka, Chalmers Joanne, Williams Hywel C. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology Journal of investigative dermatology 2015;135 (1):24-30 [PubMed]
- Teulings Hansje-Eva, Limpens Jacqueline, Jansen Sophia N., Zwinderman Aeilko H., Reitsma Johannes B., Spuls Phyllis I., Luiten Rosalie M. Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis Journal of clinical oncology 2015;33 (7):773-781 [PubMed]
- Spuls P. I., Gerbens L. A. A., Simpson E., Apfelbacher C. J., Chalmers J. R., Thomas K. S., Prinsen C. A. C., von Kobyletzki L. B., Singh J. A., Williams H. C., Schmitt J. Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement British journal of dermatology 2017;176 (4):979-984 [PubMed]
Prof. PhD P.I. Spuls (dermato-immunology and dermato-epidemiology)
Psoriasis: biologic antibodyformation, RCT etanercept versus infliximab, methotrexate optimalisation, new developments, compliance, nail psoriasis, maintenance treatment, combination treatment, guideline development, registries, quality of life, side-effect monitoring
Atopic dermatitis: harmonisation outcome parameters, new treatment options (azathioprine versus methotrexate (short and long term), systemic treatments, registry, fillagrin mutations, biomarkers, diagnostic criteria, topicals, side- effect monitoring, antibody formation dupilumab, skintypes, phenotypering, infections, pregnancy/lactation, astma and atopic dermatitis,
Rosacea: quality of life, RCT doxycyckine versus minicycline, laser treatment rosacea papulopustulosa
Off-label drug use in dermatology: RCT, guideline, Regieraad project, registry
Methodology: evidence based medicine/dermatology, guideline development, critical appraised topics, core outcome set development
Psychodermatology: ehealth Beter gestemd met de huid, shared decision making, diagnostiek psychosociale problematiek, PROMs
Vascular malformations: OVAMA core outcome set development, diagnostic criteria, PROMs
Faculty
MD PhD M.A. Middelkamp Hup
MD M.M.D. van der Linden
Others
G.A.M. Appel
P.B. Eppenga-Franklin
H.M. van der Stok
- AbbVie B.V.
- Boehringer Ingelheim BV
- Eli Lilly Cork Limited
- Europese Unie
- FONDATION RENE TOURAINE
- Het Nederlands Bijwerkingen Centrum Lareb
- IQVIA RDS Switzerland Sarl
- Janssen Cilag B.V.
- Jubilant Clinsys, Inc.
- NIEUWE DEB IND
- PAREXEL International (IRL) Limited
- Personeelsproject - Industrie
- ZonMw